Nuclear Medicine
CHOLINE
Name:
Oncopet Radiofarma®
Active Principle:
18F-Fluorocholine
Therapeutic Action:
It is indicated for the initial staging of prostate cancer as well as local regional or metastatic recurrences in the case of an increase in PSA.
Nuclear Medicine
CHOLINE
Name:
Oncopet Radiofarma®
Active Principle:
18F-Fluorocholine
Therapeutic Action:
It is indicated for the initial staging of prostate cancer as well as local regional or metastatic recurrences in the case of an increase in PSA.
RELATED PRODUCTS
-
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
AV45 (R+D)
AV45 (R+D)It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive... -
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas...

